Different Refractive Errors in Triplets With Retinopathy of Prematurity Treated With Bevacizumab

Journal of Pediatric Ophthalmology and Strabismus - United States
doi 10.3928/01913913-20120731-03
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SLACK, Inc.

Related search

Refractive Status of Chinese With Laser-Treated Retinopathy of Prematurity

Optometry and Vision Science
OptometryOphthalmology
2015English

Late Recurrence of Retinopathy of Prematurity After Treatment With Both Intravitreal Bevacizumab and Laser

Journal of AAPOS
Child HealthOphthalmologyPediatricsPerinatology
2014English

Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity

Pediatrics
Child HealthPediatricsPerinatology
2016English

Re: Vogel Et Al.: Foveal Development in Infants Treated With Bevacizumab or Laser Photocoagulation for Retinopathy of Prematurity ( Ophthalmology . 2018;125:444-452)

Ophthalmology
Ophthalmology
2018English

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2015English

Acute Angle Closure Glaucoma in Unilateral Treated Retinopathy of Prematurity With Asymmetrical Ocular Development

Journal of Evolution of Medical and Dental Sciences
2019English

Corneal Refractive Power at the Age of 3 in Children With a History of Retinopathy of Prematurity

JAPANESE ORTHOPTIC JOURNAL
2018English

A Lower Dose of Intravitreal Bevacizumab Effectively Treats Retinopathy of Prematurity

Journal of AAPOS
Child HealthOphthalmologyPediatricsPerinatology
2018English

Intravitreal Bevacizumab for Retinopathy of Prematurity in Infants Ineligible for Laser Therapy*

Turkish Journal of Medical Sciences
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy